- Enabling Economic Recovery Through Innovation
- The Top 12 Science Progress Features of 2008
- Breaking: Physicist John Holdren Is Likely Pick for Science Advisor
- Looking for a Research Bailout
- Want to Work Together? The Impact of Multi-University Collabortion
- “The Single Most Effective Way to Prevent the Transmission of Disease”
- Chu Is Bringing Science Back
- National Research Council: Nanotech Safety Needs a Closer Look. Much Closer.
- Neuroscience Everywhere
- Change for America on Science and Tech Policy, Part 4: The Office of Science and Technology Policy
- CNN Decides It Can Cover Science Without Dedicated Science Reporters
- Stem Cell Recommendations for the New Administration
Stem Cell News Roundup: Dec 3, 2007
“A new way to trick skin cells into acting like embryos changes both everything and nothing at all.” Alan I. Leshner and James A. Thomson on the new advances in stem cell research. Their Op-Ed was in response to Charles Krauthammer’s Friday column claiming that the recent discoveries by Thomson and Shinya Yamanaka were a vindication of President Bush’s moral stance on the issue.
The Daily Telegraph gets into detail about the genes used to reprogram skin cells into iPS cells and the potential risks involved.
Shinya Yamanaka led one of the teams behind the iPS breakthrough and published another paper in Nature Biotechnology detailing the transformation of mouse skin cells without using the cancer-causing gene c-Myc. Wired provides a thoughtful summary, Reuters does thorough reporting, and the LA Times gives it a brief mention.
The AFP covers another new stem cell discovery coming from Georgetown Medical School and the Washington Regional Transplant Community (WRTC) that turns primordial germinal cells (i.e.: precursors to spermatazoids) into colonies with characteristics similar to stem cells.
Wired reports that the California Institute for Regenerative Medicine will now be spending up to $13 million in 2008 on non-embryonic stem cell research. Also: CIRM’s recent auditing by the State Controller due to a conflict-of-interest issue.
The Guardian Weekly features an interview with bioethicist Darryl Macer about the ethics of cloning and embryonic research.
Comments on this article